首页> 美国卫生研究院文献>Springer Open Choice >Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
【2h】

Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction

机译:代谢操纵器:对抗线粒体功能障碍的有力策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Whilst the pathophysiology and genetics of mitochondrial disease are slowly being unraveled, currently no effective remedy for mitochondrial disorders is available. One particular strategy in mitochondrial medicine presently under study is metabolic manipulation. This approach is aimed at counteracting the deranged cell biological homeostasis caused by mitochondrial dysfunction, using dietary modifications or small molecule therapy. Cell biological alterations caused by mitochondrial dysfunction include increased reactive oxygen species production, enhanced lipid peroxidation and altered cellular calcium homeostasis. This review covers the five principles of metabolic manipulation: (1) prevention of oxidative damage by reactive oxygen species, (2) amelioration of lipid peroxidation, (3) correction of altered membrane potential, (4) restoration of calcium homeostasis, and (5) transcription regulation interference. We hypothesize that a combination of compounds targeting different metabolic pathways will abolish cellular disturbance arising as a consequences of mitochondrial dysfunction, and thereby improve or stabilize clinical features. However, only a handful of compounds have reached efficacy testing in mammals, and it remains unknown to what extent metabolic manipulation will affect the whole organism. Until a potent remedy is found, patients will remain dependent on supportive, not curative, interventions.
机译:尽管线粒体疾病的病理生理学和遗传学正在慢慢被阐明,但目前尚无针对线粒体疾病的有效疗法。目前正在研究的线粒体医学的一种特殊策略是代谢操纵。该方法旨在通过饮食改良或小分子疗法来抵消由线粒体功能障碍引起的细胞生物学稳态紊乱。线粒体功能障碍引起的细胞生物学改变包括增加的活性氧产生,增强的脂质过氧化作用和改变的细胞钙稳态。这篇综述涵盖了代谢操纵的五项原则:(1)防止活性氧引起的氧化损伤;(2)脂质过氧化的改善;(3)改变膜电位的校正;(4)钙稳态的恢复;(5) )转录调控干扰。我们假设针对不同代谢途径的化合物的组合将消除由于线粒体功能障碍而引起的细胞紊乱,从而改善或稳定临床特征。然而,只有少数化合物在哺乳动物中达到了功效测试,并且尚不清楚代谢操纵将在多大程度上影响整个生物体。在找到有效的治疗方法之前,患者将继续依赖支持性而非治疗性干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号